UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial

Arthritis & rheumatology (Hoboken, N.J.), 2019-07, Vol.71 (7), p.1174-1184

2019

Volltextzugriff (PDF)

Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing?

Nutrients, 2021-10, Vol.13 (11), p.3835

2021

Volltextzugriff (PDF)

The Spanish version of the Fibromyalgia Rapid Screening Tool: translation, validity and reliability

Rheumatology (Oxford, England), 2013-12, Vol.52 (12), p.2283-2291

2013

Volltextzugriff (PDF)

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

The lancet. Diabetes & endocrinology, 2018-06, Vol.6 (6), p.445-454

2018

Volltextzugriff (PDF)

Management of glucocorticoid-induced osteoporosis

Aging clinical and experimental research, 2021-04, Vol.33 (4), p.793-804

2021

Volltextzugriff (PDF)

Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment

Journal of bone and mineral research, 2022-06, Vol.37 (6), p.1136-1146

2022

Volltextzugriff (PDF)

Correction to: Management of glucocorticoid-induced osteoporosis

Aging clinical and experimental research, 2022-12, Vol.34 (12), p.3185-3185

2022

Volltextzugriff (PDF)

The Discriminatory Ability of the Fibromyalgia Rapid Screening Tool (FiRST): An International Study in Spain and Four Latin American Countries

Pain medicine (Malden, Mass.), 2016-05, Vol.17 (5), p.931-939

2016

Volltextzugriff (PDF)

Argentine guidelines for the diagnosis, prevention and treatment of osteoporosis, 2015

Medicina (Buenos Aires), 2017, Vol.77 (1), p.46-60

2017

Volltextzugriff (PDF)

Guidelines for the diagnosis, prevention and treatment of osteoporosis, 2012

Medicina (Buenos Aires), 2013, Vol.73 (1), p.55-74

2013

Volltextzugriff (PDF)

The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city of Buenos Aires province

Journal of clinical rheumatology, 2010-10, Vol.16 (7), p.317

2010

Volltextzugriff (PDF)

A Risk Assessment Tool (OsteoRisk) for Identifying Latin American Women with Osteoporosis

Journal of general internal medicine : JGIM, 2005-03, Vol.20 (3), p.245-250

2005

Volltextzugriff (PDF)

FRAX: a new instrument for calculating 10-year absolute fracture risk

Medicina (Buenos Aires), 2009, Vol.69 (5), p.571-575

2009

Volltextzugriff (PDF)

P217 Efficacy and safety of filgotinib for patients with RA naïve to MTX therapy: FINCH3 primary outcome results

Rheumatology (Oxford, England), 2020-04, Vol.59 (Supplement_2)

2020

Volltextzugriff (PDF)

Effects of Amerindian Genetic Ancestry on Clinical Variables and Therapy in Patients with Rheumatoid Arthritis

Journal of rheumatology, 2017-12, Vol.44 (12), p.1804

2017

Volltextzugriff (PDF)

Guías Argentinas para el diagnóstico, la prevención y el tratamiento de la osteoporosis 2015

Medicina (Buenos Aires), 2017-02, Vol.77 (1), p.46-60

2017

Volltextzugriff (PDF)

Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity?

Medicine (Baltimore), 1989-01, Vol.68 (1), p.58-65

1989

Volltextzugriff (PDF)

Guías 2012 para el diagnóstico, la prevención y el tratamiento de la osteoporosis

Medicina (Buenos Aires), 2013-02, Vol.73 (1), p.55-74

2013

Volltextzugriff (PDF)

FRAX TM: un nuevo instrumento para calcular el riesgo absoluto de fracturas a 10 años

Medicina (Buenos Aires), 2009-10, Vol.69 (5), p.571-575

2009

Volltextzugriff (PDF)

Comment on study of deflazacort versus prednisone in the treatment of chronic inflammatory disorders

Arthritis and rheumatism, 1992-07, Vol.35 (7), p.841-841

1992

Volltextzugriff (PDF)

Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease

The journal of clinical endocrinology and metabolism, 2021-02, Vol.106 (2), p.397-409

2021

Volltextzugriff (PDF)

Denosumab Safety and Efficacy Among Subjects in the FREEDOM Extension Study With Mild-to-Moderate Chronic Kidney Disease

The journal of clinical endocrinology and metabolism, 2020-11

2020

Volltextzugriff (PDF)

Vitamin D Megadose: Definition, Efficacy in Bone Metabolism, Risk of Falls and Fractures

Open access rheumatology: research and reviews, 2020-01, Vol.12, p.105-115

2020

Volltextzugriff (PDF)

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control

Diabetes, obesity & metabolism, 2009-10, Vol.11 (10), p.947-952

2009

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(24)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(15)
Female
(10)
Medicine, General & Internal
(9)
Male
(8)
Middle Aged
(8)
Aged
(6)
Bone Mineral Density
(6)
General & Internal Medicine
(6)
Osteoporosis
(6)
Rheumatology
(6)
Bone Density
(5)
Fractures
(5)
Adult
(4)
Endocrinology & Metabolism
(4)
Argentina
(3)
Bone Density Conservation Agents - Therapeutic Use
(3)
Denosumab
(3)
Disease
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial

Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing?

The Spanish version of the Fibromyalgia Rapid Screening Tool: translation, validity and reliability

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

Management of glucocorticoid-induced osteoporosis

Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment

Correction to: Management of glucocorticoid-induced osteoporosis

The Discriminatory Ability of the Fibromyalgia Rapid Screening Tool (FiRST): An International Study in Spain and Four Latin American Countries

Argentine guidelines for the diagnosis, prevention and treatment of osteoporosis, 2015

Guidelines for the diagnosis, prevention and treatment of osteoporosis, 2012

The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city of Buenos Aires province

A Risk Assessment Tool (OsteoRisk) for Identifying Latin American Women with Osteoporosis

FRAX: a new instrument for calculating 10-year absolute fracture risk

P217 Efficacy and safety of filgotinib for patients with RA naïve to MTX therapy: FINCH3 primary outcome results

Effects of Amerindian Genetic Ancestry on Clinical Variables and Therapy in Patients with Rheumatoid Arthritis

Guías Argentinas para el diagnóstico, la prevención y el tratamiento de la osteoporosis 2015

Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity?

Guías 2012 para el diagnóstico, la prevención y el tratamiento de la osteoporosis

FRAX TM: un nuevo instrumento para calcular el riesgo absoluto de fracturas a 10 años

Comment on study of deflazacort versus prednisone in the treatment of chronic inflammatory disorders

Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease

Denosumab Safety and Efficacy Among Subjects in the FREEDOM Extension Study With Mild-to-Moderate Chronic Kidney Disease

Vitamin D Megadose: Definition, Efficacy in Bone Metabolism, Risk of Falls and Fractures

Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control

Suchergebnisse filtern